A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost
- 26 January 2007
- Vol. 25 (7) , 1214-1224
- https://doi.org/10.1016/j.vaccine.2006.10.009
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from MonkeypoxJournal of Virology, 2006
- Ectromelia virus: the causative agent of mousepoxJournal of General Virology, 2005
- Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in MiceJournal of Virology, 2005
- Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challengeVaccine, 2005
- Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine responseVaccine, 2004
- Smallpox Vaccines: Looking Beyond the Next GenerationScience, 2004
- Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challengeVaccine, 2004
- Containing Bioterrorist SmallpoxScience, 2002
- Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1–KLH and GD3–KLH conjugatesVaccine, 2000
- Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptideGene, 1991